Top

Published in:

01-01-2015 | Letter to the Editor

Authors’ Reply to Ahmad SR: “Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries”

Authors: Florence Margraff, Delphine Bertram

Published in: Drug Safety | Issue 1/2015

Excerpt

First of all, we thank Dr. Syed Rizwanuddin Ahmad for his well-advised comments [1] and for offering us the opportunity to clarify a number of points from our work [2]. …

Ahmad SR. Comment on: adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf. 2014. doi:10.1007/s40264-014-0241-0

Margraff F, Bertram D. Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf. 2014;37(6):409–19.PubMedCrossRef

Ahmad SR, Goetsch RA, Marks NS. Spontaneous reporting in the United States. In: Strom BL, editor. Pharmacoepidemiology, chapter 9. Chichester: Wiley; 2005. pp. 135–159.

Van Hunsel F, Härmark L, Pal S, Olsson S, Van Grotheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35(1):45–60.PubMedCrossRef

Title: Authors’ Reply to Ahmad SR: “Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries”
Authors: Florence Margraff
Delphine Bertram
Publication date: 01-01-2015
Publisher: Springer International Publishing
Published in: Drug Safety / Issue 1/2015
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI: https://doi.org/10.1007/s40264-014-0242-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Authors’ Reply to Ahmad SR: “Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries”

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

Bacillus Calmette-Guérin (BCG) Vaccine Adverse Events in Victoria, Australia: Analysis of Reports to an Enhanced Passive Surveillance System

Comment on: “Desideratum for Evidence-Based Epidemiology”

Safety Considerations with Pharmacological Treatment of Gestational Diabetes Mellitus

Comment on: “Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries”

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

The US Food and Drug Administration-European Medicines Agency Collaboration in Pharmacovigilance: Common Objectives and Common Challenges